What's new

EMEA-003389-PIP01-23

EMEA-003389-PIP01-23

Mar 17, 2025 - 16:38
 0
EMEA-003389-PIP01-23
EMEA-003389-PIP01-23
Read More

Tags:

Previous Article

Curevo rounds up $110M to challenge GSK’s Shringrix, nabs Moncef Slaoui to lead ...

Next Article

The D Brief: Strikes in Yemen; Border destroyer; DOGE vs. nuclear-security agenc...

Related Posts

Human medicines European public assessment report (EPAR): Advagraf, tacrolimus, Date of authorisation: 23/04/2007, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 27, 2025  0

Human medicines European public assessment report (EPAR): Fasenra, benralizumab, Date of authorisation: 08/01/2018, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 14, 2025  0

Human medicines European public assessment report (EPAR): Xoterna Breezhaler, indacaterol,glycopyrronium bromide, Date of authorisation: 18/09/2013, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 3, 2025  0